Skip to main content
Log in

Temporal aspects of glucocorticoid action and clinical implications

  • Editorials
  • Published:
Ricerca in clinica e in laboratorio

Summary

Administration of glucocorticoids is effective and necessary in various diseases, but the appearance of side effects may compromise its results. Timing as well as dosing designed to obtain, for the highest number of patients, maximal beneficial effects with minimal undesired effects, is particularly pertinent to long-term corticosteroid therapy, in view of the rhythms exhibited by the endogenous secretion of adrenal cortical and coordinating hormones, primarily ACTH. In experimental animals, properly-timed circadian treatment can be preferred to alternate-day treatment for avoiding certain side effects. To secure the desired effect each day rather than only on alternate days, a chronobiologically correct corticosteroid therapy seeks the best compromise between timing for most of the desired and least of the undesired effects. This was the aim in the design of a chronopluricorticoid drug, with the time specification on its label. The clinical use of this preparation allowed the inferential statistical demonstration of a rhythmic circadian organization maintained during therapy, while the pharmacological results gained were similar to those obtained by the conventional administration of larger doses of corticoids.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Agrimonti F., Angeli A., Fraria R., Fazzari A. M., Tamagnone C., Fornaro D., Ceresa F.: Circannual rhythmicities of cortisol levels in the peripheral plasma of healthy adult subjects—Chronobiologia9, 107, 1982.

    PubMed  CAS  Google Scholar 

  2. Agrimonti F., Boggio-Bertinet D., Balzola F., Angeli A.: Circadian profile of plasma cortisol and aldosterone in post-traumatic comatose patients under high-dose dexamethasone treatment—J. endocr. Invest.4, 49, 1981.

    PubMed  CAS  Google Scholar 

  3. Anceli A.: Rhythmicity of pituitary hormone secretion. In:Motta M., Zanisi M., Piva F. (Eds): Pituitary hormones and related peptides. Serono Symposium no. 49. Academic Press, London, New York and San Francisco, 1982; p. 319.

    Google Scholar 

  4. Bixby L., Levi F., Haus R., Sackett L., Haus E., Halberg F., Hrushesky W.: Circaseptan aspects of cisplatine (CP) murine nephrotoxicity—Chronobiologia6, 80, 1979. (Abstract).

    Google Scholar 

  5. Carter M. E., James V. H. T.: Effect of alternate-day, single dose corticosteroid therapy on pituitary-adrenal function—Ann. rheum. Dis.31, 379, 1972.

    PubMed  CAS  Google Scholar 

  6. Ceresa F.: Chronopharmacological attempt to avoid the inhibitory corticoid effect during long-term treatment—Chronobiologia1 (Suppl. 1), 271, 1974.

    PubMed  Google Scholar 

  7. Ceresa F., Angeli A.: Chronothérapie corticoide. In:Mirouze J. (Ed.): XIV Congres International de Thérapeutique. L'Expansion Scientifique Française, Paris, 1977; p. 211.

    Google Scholar 

  8. Ceresa F., Angeli A., Boccuzzi G., Molino G.: Once-a-day neurally stimulated and basal ACTH secretion phases in man and their response to corticoid inhibition—J. clin. Endocr.29, 1074, 1969.

    PubMed  CAS  Google Scholar 

  9. Copinschi G., Leclercq R., Goldstein J., Robyn C., Delsir D., De Laet M. H., Virasoro E., Vanhaelst L., L'Hermite M., Van Cauter E.: Seasonal modifications of circadian and ultradian variations of ACTH, cortisol, βMSH, hPRL and TSH in normal man— Chronobiologia4, 106, 1977. (Abstract).

    Google Scholar 

  10. Daly J. R., Evans J. I.: Daily rhythms of steroid and associated pituitary hormones in man and their relationship to sleep—Advanc. Steroid Biochem. Pharmacol.4, 61, 1974.

    CAS  Google Scholar 

  11. De Vecchi A., Cantaluppi A., Montagnino G., Tarantino A., Maestri O., Ponticelli C.: Long-term comparison between single-morning daily and alternate-day steroid treatment in cadaver kidney recipients—Transplant. Proc.12, 327, 1980.

    PubMed  Google Scholar 

  12. De Vecchi A., Carandente F., Fryd D. S., Halberg F., Sutherland D. E., Howard R. J., Simmons R. L., Najarian J. S.: Circaseptan (about 7-day) rhythm in human kidney allograft rejection in different geographic locations. In:Reinberg A., Halberg F. (Eds): Chronopharmacology. Pergamon Press, Oxford, 1979; p. 193.

    Google Scholar 

  13. De Vecchi A., Halberg F., Sothern R. B., Cantaluppi A., Ponticelli C.: Circasepian rhythmic aspects of rejection in treated patients with kidney transplant. In:Walker C. A., Winget C. M., Soliman K. F. A. (Eds): Chronopharmacology and chronotherapeutics. Florida A and M University Foundation, Tallahassee, 1981; p. 339.

    Google Scholar 

  14. De Vecchi A., Ponticelli C.: A survey of current steroid regimens for transplant patients— Heart Transplant.2, 64, 1982.

    Google Scholar 

  15. Di Raimondo V. C., Forsham P. H.: Some clinical implications of the spontaneous diurnal variation in adrenal cortical secretory activity—Amer. J. Med.21, 321, 1956.

    Article  Google Scholar 

  16. Eratalay J. K., Simmons D. J., El-Mofty S. K., Rosenberg G. D., Nelson W., Haus E., Halberg F.: Methylprednisolone chronopharmacology: bone growth in the rat mandible following every-day or alternate-day schedules—Arch. oral Biol.26, 769, 1981.

    Article  PubMed  CAS  Google Scholar 

  17. Fauci A. S.: Alternate-day corticosteroid therapy—Amer. J. Med.64, 729, 1978.

    Article  PubMed  CAS  Google Scholar 

  18. Frev F. J., Amend W. J. C., Lozada F., Frey B. M., Holford N. H. G., Benet L. Z.: Pharmacokinetics of prednisolone and endogenous hydrocortisone levels in cushingoid and non-cushingoid patients—Europ. J. clin. Pharmacol.21, 235, 1981.

    Article  Google Scholar 

  19. Halberg F.: Some physiological and clinical aspects of 24-hour periodicity—J. Lancet (USA)73, 20, 1953.

    CAS  Google Scholar 

  20. Halberg F.: Organisms as circadian systems; temporal analysis of their physiologic and pathologic responses, including injury and death. In: Walter Reed Army Institute of Research Symposium, Medical Aspects of Stress in the Military Climate. April 1964; p. 1.

  21. Halberg F., Halberg E., Barnum C. P., Bittner J. J.: Physiologic 24-hour periodicity in human beings and mice, the lighting regimen and daily routine. In:Withrow R. B. (Ed.): Photoperiodism and related phenomena in plants and animals. Ed. Publ. # 55, Amer. Ass. Advanc. Sci., Washington, D.C., 1959; p. 803.

    Google Scholar 

  22. Halberg F., Halberg E., Halberg J.: Collateral-interacting hierarchy of rhythm coordination at different organization levels, changing schedules and aging. In:Suda M., Hayaishi O., Nakagawa H. (Eds): Biological rhythms and their central mechanism. Naito Foundation, Elsevier/North-Holland Biomedical Press, Arnsterdam, 1979; p. 421. (See also discussion pp. 435–438).

    Google Scholar 

  23. Halberg F., Halberg E., Herold M., Vecsei P., Günther R., Reinberg A.: Toward a clinospectrometry of conventional and novel effects of ACTH 1·17—Synchrodyn®—in rodents and human beings. In:Takahashi R., Walker C., Halberg F. (Eds): Toward chronopharmacology. Proc. 8th IUPHAR Congr. and Sat. Symposia, Nagasaki July 27–28, 1981. Pergamon Press, Oxford-New York, 1932; p. 119.

    Google Scholar 

  24. Halberg F., Halberg E., Runge W., Wicks J., Cadotte L., Yunis E., Katinas G., Stutman O.: Transplant chronobiology. In:Scheving L. E., Halberg F., Pauly J. E. (Eds): Chronobiology. Igaku Shoin Ltd., Tokyo, 1974; p. 320.

    Google Scholar 

  25. Halberg F., Lubanovic W. A., Sothern R. B., Brockway B., Powell E. W., Pasley J. N., Scheving L. E. Nornifensine chronopharmacology, schedule shifts and circadian temperature rhythms in di-suprachiasmatically lesioned rats. Modeling emotional chronopathology and chronotherapy—Chronobiologia6, 405, 1979.

    PubMed  CAS  Google Scholar 

  26. Halberg F., Reinberg A.: Rythmes circadiens et rythmes de basse fréquence en physiologie humaine—J. Physiol. (Paris),59, 117, 1967.

    CAS  Google Scholar 

  27. Harter J. G.: Corticosteroids, their physiologic use in allergic disease—N.Y. St. J. Med.66, 827, 1966.

    Google Scholar 

  28. Harter J. G., Reddy W. J., Thorn G. W.: Studies on an intermittent corticosteroid dosage regimen—New Engl. J. Med.296, 591, 1963.

    Google Scholar 

  29. Haus E., Halberg F.: Endocrine rhythms. In:Scheving L. E., Halberg F. (Eds): Chronobiology. Principles and applications to shifts in schedules. Sijthoff and Noordhoff, Alphen aan den Rijn, The Netherlands, and Rockville, Md., 1980; p. 137.

    Google Scholar 

  30. Hopkins H.A., Ritenour R. E., MacLeod M., Looney W. B.: The effect of varying the time between irradiation and cyclophosphamide on growth response of hepatoma 3924 A—Int. J. Radiat. Oncol. Biol. Phys.5, 1455, 1979.

    PubMed  CAS  Google Scholar 

  31. Hunder G. G., Sheps S. G., Allen G. L., Joyce J. W.: Daily and alternate day corticosteroid regimens in treatment of giant cell arteritis—Ann. intern. Med.82, 513,1975.

    Google Scholar 

  32. Kaneko M., Kaneko K., Shinsako J., Dallman M. F.: Adrenal sensitivity to adrenocorticotropi (ACTH) varies diurnally—Endocrinology109, 70, 1981.

    PubMed  CAS  Google Scholar 

  33. Knapp M. S., Pownall R.: Chronobiology, pharmacology and the immune system—Int. J. Immunopharmacol.2, 91, 1980.

    Article  Google Scholar 

  34. Krieger D. T.: Rhythms in CRF, ACTH, and corticosteroids. In:Kriecer D. T. (Ed.): Endocrine rhythms. Raven Press, New York, 1979; p. 123.

    Google Scholar 

  35. Kriecer D. T., Allen W., Rizzo F.: Characterization of the normal pattern of plasma corticosteroid levels—J. clin. Endocr.32, 266, 1971.

    Google Scholar 

  36. Levi F., Halberg F.: Circaseptan (about-7-day) bioperiodicity—spontaneous and reactive— and the search for pacemakers—La Ricerca Clin. Lab.12, 323, 1982.

    CAS  Google Scholar 

  37. Liddle G. W.: The adrenals. In:Williams R. M. (Ed.): Textbook of endocrinology, W. B. Saunders Co., Philadelphia, London and Toronto, 1981; 6th ed., chapter. 5, p. 249.

    Google Scholar 

  38. MacGill P. E., Grieg W. R., Browning M., Boyle J. A.: Plasma cortisol response to Synacthen (ACTH 1–24 Ciba) at different times of the day in patients with rheumatic disease.— Ann. rheum. Dis.26, 123, 1967.

    Google Scholar 

  39. Meier A. H.: Daily variation in concentration of plasma corticosteroids in hypophysectomized rats—Endocrinology98, 1475, 1976.

    PubMed  CAS  Google Scholar 

  40. Menaker M., Takahashi J. S., Eskin A.: The physiology of circadian pacemakers—Ann. Rev. Physiol.40, 501, 1978.

    Article  CAS  Google Scholar 

  41. Montalbetti N.: Non-interference in circadian rhythm during clinical use of corticoids— Chronobiologia1 (Suppl. 1), 281, 1974.

    Google Scholar 

  42. Moore-Ede M. C.: Circadian rhythms of drug effectiveness and toxicity—Clin. Pharmacol. Ther.14, 925, 1973.

    CAS  Google Scholar 

  43. Nichols T., Nugent C. A., Tyler G. H.: Diurnal variation in suppression of adrenal function by glucocorticoids—J. clin. Endocr.25, 343, 1965.

    PubMed  CAS  Google Scholar 

  44. Pincus G.: A diurnal rhythm in the excretion of urinary ketosteroids by young men—J. clin. Endocr.3, 195, 1943.

    CAS  Google Scholar 

  45. Ratte J., Halberg F., Kühl J. F. W., Najarian J. S.: Circadian and circaseptan variations in rat kidney allograft rejection. In:McGovern J., Reinberg A., Smolensky M. (Eds) Chronobiology in allergy and immunology. C. Thomas, Springfield, 1977; p. 250.

    Google Scholar 

  46. Reed W. P., Lucas Z. J., Cohn R.: Alternate-day prednisone therapy after renal transplantation —Lanceti, 747, 1970.

    Article  Google Scholar 

  47. Rees L. H., Holdaway I. M., Phenekos C., Besser G. M., Landon J.: ACTH secretion and clinical investigations. In:Franchimont P. (Ed.): Aspects of hypothalamic regulation of endocrine function. Schattauer Verlag, Stuttgart and New York, 1975; p. 457.

    Google Scholar 

  48. Reinberg A., Gervais P., Chaussade M., Fraboulet G., Duburque B.: Circadian changes in effectiveness of corticosteroids in eight patients with allergic asthma—J. Allergy. (In press).

  49. Reinberg A., Guillemant N. J., Touitou Y., Dupont M., Lagoguey M., Bourgeois P., Briere L., Fraboulet G., Guillet P.: Clinical chronopharmacology of ACTH-1-17. Effects on plasma cortisol and urinary 17-hydroxycorticosteroids—Chronobiologia7, 513, 1980.

    PubMed  CAS  Google Scholar 

  50. Reinberg A., Guillet P., Gervais P., Ghata J., Vignaud D., Abulker C.: One-month chronocorticotherapy (Dutimelan® 8.15 mite). Control of the asthmatic condition without adrenal suppression and circadian rhythm alteration—Chronobiologia4, 295, 1977.

    PubMed  CAS  Google Scholar 

  51. Reinberg A., Halberg F., Falliers C.: Circadian timing of methylprednisolone effects in asthmatic boys—Chronobiologia1, 333, 1974.

    PubMed  CAS  Google Scholar 

  52. Reinberg A., Lagoguey M.: Annual endocrine rhythms in healthy young adult men: thein implication in human biology and medicine. In:Assenmacher I., Farner D. S. (Eds): Environmental endocrinology. Springer-Verlag, Berlin, Heidelberg and New York 1978: p. 113.

    Google Scholar 

  53. Reinberg A., Touitou Y., Levi F.: Rythmes circadiens et circannuels d'epreuves fontionnelles en endocrinologie.—Ann. Endocr. (Paris). (In press).

  54. Rietveld W. J., Groos G. A.: The central neural regulation of circadian rhythms. In:Scheving L. E., Halberg F. (Eds): Chronobiology. Principles and applications to shifts in schedules. Sijthoff and Noordhoff, Alphen aan den Rijn, The Netherlands, and Rockville. Md., 1980; p. 182.

    Google Scholar 

  55. Sanchez De la Peña S., Halberg F., Ungar F.: Pineal chronomodulation the feed sideward— Clin. Chem. Newsletter2, 129, 1982.

    Google Scholar 

  56. Sanchez de la Peña S., Halberg F., Ungar F., Haus E., Lakatua D., Sanchez E., Vecsei P., Scheving L. E.: Circadian rhythmic pineal modulation of pituitary effect on murine adrenal corticosterone productionin vitro—Brain Res. Bull. (In press).

  57. Sanchez de la Peña S., Ungar F., Halberg F., Sanchez E., Yunis E., Vecsei P.: Circadian and infradian variation in murine adrenal corticosterone production—a test system for Synchrodyn. In:Takahashi R., Walker C., Halberg F. (Eds): Toward chronopharmacology. Proc. 8th IUPHAR Congr. and Sat. Symposia, Nagasaki, July 27–28, 1981. Pergamon Press, Oxford-New York, 1982; p. 319.

    Google Scholar 

  58. Scheving L. E., Tsai T. H., Powell E. W., Pasley J. N., Halberg F., Dunn J.: Bilateral lesions of suprachiasmatic nuclei affect circadian rhythms in [3H]-thymidine incorporation into deoxyribonucleic acid in mouse intestinal tract, mitotic index of corneal epithelium and serum corticosterone—Anat. Rec. (In press).

  59. Smolensky M. H., Halberg F., Pitts G. C., Nelson W.: The chronopharmacology of methylprednisolone: clinical implications of animal studies with special emphasis upon the moderation of growth inhibition by timing to circadian rhythms. In:Smolensky M. H., Reinberg A., McGovern J. P. (Eds): Recent advances in the chronobiology of allergy and immunology. Pergamon Press, Oxford, 1981; p. 137.

    Google Scholar 

  60. Soutar C. A., Costello J., Ihaduola O., Turner-Warwick M.: Nocturnal and early morning asthma. Relationship to plasma corticosteroid and response to cortisol infusion—Thorax30, 436, 1975.

    Article  PubMed  CAS  Google Scholar 

  61. Uezono K., Sackett-Lundeen L., Kawasaki T., Haus E.: Circaseptan rhythm in clinically healthy human subjects—Int. J. Chronobiol.7, 340, 1981.

    Google Scholar 

  62. Ungar F., Halberg F.: Circadian rhythm in thein vitro response of mouse adrenal to adrenocorticotropic hormone—Science137, 1058, 1962.

    Article  PubMed  CAS  Google Scholar 

  63. Weitzman E. D.: Circadian rhythms and episodic hormone secretion in man—Ann. Rev. Med.27, 225, 1976.

    Article  PubMed  CAS  Google Scholar 

  64. Zbiegieni B. M.: Diurnal and seasonal changes in ascorbic acid level in adrenal glands of laboratory mice—Bull. Acad. pol. Sci. (Physiol.)27, 653, 1980.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Contribution invited and delivered by the Senior Author at a Symposium coorganized by the American Society of Toxicology and the Society for Experimental Pharmacology and Therapeutics, held in Louisville, Kentucky, USA, on August 15–19, 1982.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Angeli, A., Carandente, F. & Halberg, F. Temporal aspects of glucocorticoid action and clinical implications. La Ricerca Clin. Lab. 13, 203–217 (1983). https://doi.org/10.1007/BF02904834

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02904834

Key-words

Navigation